microRNAs and oligometastasis

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

microRNAs and oligometastasis

Abstract

References

Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells.

Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells.

MicroRNA expression characterizes oligometastasis(es)

Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs

Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs

14q32-encoded microRNAs mediate an oligometastatic phenotype

Citations

Local therapy combined with chemotherapy versus chemotherapy for postoperative oligometastatic non-small-cell lung cancer

Definition, Biology, and History of Oligometastatic and Oligoprogressive Disease.

Developments in oligometastatic hormone-sensitive prostate cancer

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.

Role of 18F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review.

Related Concepts

Related Feeds

Aging Genetics (Keystone)

Related Papers

Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung

Whipple's procedure for an oligometastasis to the pancreas from a leiomyosarcoma of the thigh.

Locally ablative non-surgical management of colo-rectal liver metastasis.

Stereotactic body radiotherapy for oligometastatic lung tumors

Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.